Komek et al., 2012) a relevant role in the generating and modulating gamma activity, via regulation of GABAergic (Andersson et al., 2012b) and glutamatergic transmission (Andersson et al., 2012a), is also played by dopamine (Herrmann and Demiralp, 2005; Furth et al., 2013), a key neurotransmitter in the pathophysiology of schizophrenia. Due to action of dopamine receptor antagonists in suppressing the gamma activity in humans (Ahveninen et al., 2000) and in animal models (Dejean et al., 2011), we could speculate that prolonged exposition to antipsychotics might account for the decreased gamma connectivity observed in the LDD group.
